Phase I trial of oral irinotecan and temozolomide for children with relapsed high-risk neuroblastoma: a new approach to neuroblastoma therapy consortium study - Wagner, L M; Villablanca, J G; Stewart, C F (J Clin Oncol, 2009)
et al.